Have a personal or library account? Click to login
Development of semisolid pharmaceutical forms with mometasone furoate Cover

Development of semisolid pharmaceutical forms with mometasone furoate

Open Access
|Dec 2023

References

  1. Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity and aging. Immunology. 2020;160(2):116-25.
  2. Iqbal B, Ali J, Baboota S. Recent advances and development in epidermal and dermal drug deposition enhancement technology. Int J Dermatol. 2018;57(6):646-60.
  3. Neubert RHH. Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm. 2011;77(1):1-2.
  4. Mahalingam R, Li X, Jasti BR. Semisolid dosages: ointments, creams, and gels. Pharm Manuf Handb. 2008;1:267-312.
  5. Chang C, Zhang L. Cellulose-based hydrogels: Present status and application prospects. Carbohyd Polym. 2011;84(1):40-53.
  6. Vlaia L, Coneac G, Olariu I, Vlaia V, Lupuleasa D. Cellulose-derivatives-based hydrogels as vehicles for dermal and transdermal drug delivery. Emerging concepts in analysis and applications of hydrogels. 2016;2:64.
  7. Shelgavkar DD, Dhole VM, Singh V, Pande S. Development and evaluation of oxiconazole nitrate hydrogel as a topical drug delivery system. Innov Pharma Pharmacother. 2017;5(2):76-83.
  8. Dhurke R, Ramyasree D. Pulsatile Delivery System for Antihypertensive Drug. Cur Asp Pharm Res Dev. 2022;9:100-10.
  9. Faergemann J, Christensen O, Sjövall P, Johnsson A, Hersle K, Nordin P, et al. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis. JEADV. 2000;14(5):393-6.
  10. Spada F, Barnes TM, Greive KA. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids. Australasian J of Dermat. 2018;59(3):e168-e74.
  11. Mijaljica D, Spada F, Harrison IP. Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations. J Fun. 2022;8(8):812.
  12. Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch dermatol. 1985;121(1):63-7.
  13. Niculet E, Bobeica C, Tatu AL. Glucocorticoid-induced skin atrophy: the old and the new. Clinic, Cosm Invest Dermatol. 2020;13:1041.
  14. Tatu AL, Ionescu MA, Nwabudike LC. Contact allergy to topical mometasone furoate confirmed by rechallenge and patch test. Am J Ther. 2018;25(4):e497-e8.
  15. Monica L-L, Jordi G, Francisco F-C. In situ bioadhesive film-forming system for topical delivery of mometasone furoate: Characterization and biopharmaceutical properties. J Drug Deliv Sci Tech. 2020;59:101852.
  16. Mehta AB, Nadkarni NJ, Patil SP, Godse KV, Gautam M, Agarwal S. Topical corticosteroids in dermatology. Ind j dermatol, vener leprol. 2016;82:371.
  17. Kurian A, Barankin B. Delivery vehicle advances in dermatology. Fam Pract Ed. 2011;7:4-5.
  18. Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm res. 1992;9(1):45-51.
  19. Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm. 2008;68(3):453-66.
  20. Shinde G, Desai P, Shelke S, Patel R, Bangale G, Kulkarni D. Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization, in vitro and in vivo performance. J Dermatol Treat. 2022;33(2):885-96.
  21. Ference JD, Last AR. Choosing topical corticosteroids. Amer fam phys. 2009;79(2):135-40.
  22. Tadicherla S, Ross K, Shenefelt PD, Fenske NA. Topical corticosteroids in dermatology. JDD. 2009;8(12):1093-105.
  23. Gabros S, Nessel TA, Zito PM. Topical corticosteroids. StatPearls Publishing, Treasure Island 2018.
  24. Raposo SSC. Pharmaceutical topical dosage forms as carriers for glucocorticoids: Universidade de Lisboa (Portugal); 2013.
  25. Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS j. 2010;12(3):263-71.
  26. Vigata M, Meinert C, Hutmacher DW, Bock N. Hydrogels as drug delivery systems: A review of current characterization and evaluation techniques. Pharm. 2020;12(12):1188.
  27. Caccavo D. An overview on the mathematical modeling of hydrogels’ behavior for drug delivery systems. Int J Pharm. 2019;560:175-90.
  28. Parashar B, Kabra A, Chandel A. Formulation and evaluation of gel containing miconazole nitrate an antifungal agent. Int J Pharm Res Rev. 2013;2(6):18-28.
  29. Panraksa P, Udomsom S, Rachtanapun P, Chittasupho C, Ruksiriwanich W, Jantrawut P. Hydroxypropyl Methylcellulose E15: A Hydrophilic Polymer for Fabrication of Orodispersible Film Using Syringe Extrusion 3D Printer. Polymers-Basel. 2020;12(11):2666.
  30. Chen H-H. Rheological properties of HPMC enhanced Surimi analyzed by small-and large-strain tests: I. The effect of concentration and temperature on HPMC flow properties. Food hydrocolloids. 2007;21(7):1201-8.
  31. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliver Rev. 2012;64:163-74.
DOI: https://doi.org/10.2478/amma-2023-0045 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 280 - 284
Submitted on: Oct 21, 2023
Accepted on: Nov 6, 2023
Published on: Dec 28, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Emőke Margit Rédai, Boglárka Jakab, Robert Alexandru Vlad, Paula Antonoaea, Nicoleta Todoran, Emese Sipos, Adriana Ciurba, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.